February 2022 FDA Recall Chlorthalidone by Sun Pharmaceutical Industries Inc
D-0578-2022 - Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup

This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries Inc on February 7, 2022 for the product Chlorthalidone. The FDA reported the reason for recall as foreign matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0578-2022

Reason for Recall
Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup
Initiated
02-07-2022
Reported
02-23-2022
Quantity
59,232 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
SUN PHARMACEUTICAL INDUSTRIES INC
Nationwide with the United States
Chlorthalidone Tablets USP 25 mg, Rx Only, 100 Tablets, Sun Pharma, Mfg. by: Fontida Bio Pharm Inc., 1100 Orthodox St. Philadephia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-648-88.

Batch or Lot Expiration Information

Lot# : P0602, Exp. Date 03/2023